A Study Comparing Sequential Satraplatin & Erlotinib to Erlotinib in Unresectable Stage 3/4 Non-small-cell Lung Cancer (NSCLC)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Corey Langer, MD
Fox Chase Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mcgill University
Montreal, Canada
- Princess Margaret Hospital
Toronto, Canada
- Hospital San Borja Arriaran
Santiago, Chile
- Instituto Nacional del Cancer
Santiago, Chile
- Research Center
Santiago, Chile
- Pacific Cancer Medical Center
Anaheim, California, United States
- Scripps Clinic
La Jolla, California, United States
- Kenmar Research Institute
Los Angeles, California, United States
- Memorial Cancer Institute
Hollywood, Florida, United States
- University of Miami Sylvester Cancer Center
Miami, Florida, United States
- Rush University Medical Center
Chicago, Illinois, United States
- Highlands Oncology Group
Bentonville, Ohio, United States
- Gabrail Cancer Center
Canton, Ohio, United States
- Cleveland Clinic Foundation
Cleveland, Ohio, United States
- Signal Point Hematology/oncology
Middleton, Ohio, United States
- Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2006
- Primary completion
- 28 Feb 2009
- Completion
- 31 Mar 2009
- Last update posted
- 7 Aug 2012
- Registered enrollment
- 100
- Registry id
- NCT00370383
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.